PMC 7416332
Weight loss is a multifaceted outcome influenced by diet, physical activity, sleep, stress, appetite, and adherence over time
Compared to GLP-1 Agonists: Weight management peptides like semaglutide and tirzepatide have demonstrated weight loss efficacy superior to AOD-9604 in clinical trials, but they also have distinct side effect profiles
Instead of calming pain long term, opioids can remodel pain-processing circuits in the brain and spinal cord, making normal sensations feel more painful
LipRSV exerted limited and region-dependent redox effects, reducing ROS levels only in the hippocampus, cerebellum, and posterior cortex, while failing to improve behavioral outcomes and being associated with unfavorable neurochemical alterations, including reduced BDNF and NGF levels